Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
J
J
Mallolas
L
L
Zamora
J M
JM
Gatell
J M
JM
Miró
E
E
Soriano
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D003622:Dapsone / Q000627:therapeutic use; D005500:Follow-Up Studies; D006801:Humans; D010419:Pentamidine / Q000627:therapeutic use; D011020:Pneumonia, Pneumocystis / Q000517:prevention & control*; D011739:Pyrimethamine / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use
D010419:Pentamidine; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D003622:Dapsone; D011739:Pyrimethamine